ZELDIS JEROME B — SEC Form 4 filings
SEC reporting owner CIK 1433982. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-16 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 13,636 shares, $34,999 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 6 legs across 2 filings — 44,000 shares, $2,000,697 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 20,000 shares @ $38.24 ($764,800) in PTC THERAPEUTICS, INC., filed 2024-05-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. (PTCT) | Director | 5 | — | 6 legs · 44,000 sh · $2,000,697 | 12 |
| NEXGEL, INC. (NXGL) | Director | 4 | 2 legs · 13,636 sh · $34,999 | — | 4 |
| SOLIGENIX, INC. (SNGX) | Director | 3 | — | — | 3 |
Form 4 filings — ZELDIS JEROME B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | SOLIGENIX, INC. (SNGX) | Grant/award (A): 78,947 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 3,475 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | NEXGEL, INC. (NXGL) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | SOLIGENIX, INC. (SNGX) | Grant/award (A): 17,647 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 8,800 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | SOLIGENIX, INC. (SNGX) | Grant/award (A): 8,646 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Option exercise (M): 12,000 @ $51 · Sale (S): 8,813 @ $51.44 · Sale (S): 3,187 @ $52.42 · Option exercise (M): 12,000 @ $30.86 · Sale (S): 5,699 @ $50.52 · Sale (S): 2,634 @ $51.43 · +3 more | EDGAR |
| 2024-11-22 | 4 | NEXGEL, INC. (NXGL) | Purchase (P): 3,636 @ $2.75 · Grant/award (A): 1,818 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | NEXGEL, INC. (NXGL) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-08-27 | 4 | NEXGEL, INC. (NXGL) | Purchase (P): 10,000 @ $2.50 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Option exercise (M): 20,000 @ $26.42 · Sale (S): 20,000 @ $38.24 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1433982 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →